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Abstract. Two peroxisomal targeting signals, PTS1 and 
PTS2, are involved in the import of proteins into the 
peroxisome matrix. Human patients with fatal general- 
ized peroxisomal deficiency disorders fall into at least 
nine genetic complementation groups. Cells from many 
of these patients are deficient in the import of PTS1- 
containing proteins, but the causes of the protein- 
import defect in these patients are unknown. We have 
cloned and sequenced the human cDNA homologue 
(PTS1R) of the Pichiapastoris  PAS8 gene, the PTS1 re- 
ceptor (McCollum, D., E. Monosov, and S. Subramani. 
1993. J. Cell Biol.  121:761-774). The PTS1R mRNA is 
expressed in all human tissues examined. Antibodies to 
the human PTS1R recognize this protein in human, 
monkey, rat, and hamster cells. The protein is localized 
mainly in the cytosol but is also found to be associated 
with peroxisomes. Part of the peroxisomal PTS1R pro- 
tein is tightly bound to the peroxisomal membrane. An- 
tibodies to PTS1R inhibit peroxisomal protein-import 
of PTSl-containing proteins in a permeabilized CHO 
cell system. In vitro-translated PTS1R protein specifi- 
cally binds a serine-lysine-leucine-peptide. A PAS8- 
PTS1R fusion protein complements the P. pastoris 
pas8 mutant. The PTS1R cDNA also complements the 
PTS1 protein-import defect in skin fibroblasts from 
patients--belonging to complementation group two-- 
diagnosed as having neonatal adrenoleukodystrophy or 
Zellweger syndrome. The PTS1R gene has been local- 
ized to a chromosomal location where no other peroxi- 
somal disorder genes are known to map. Our findings 
represent the only case in which the molecular basis of 
the protein-import deficiency in human peroxisomal 
disorders is understood. 
T 
RANSPORT of proteins into  the peroxisomal matrix 
occurs via at least two pathways dependent on dis- 
tinct  peroxisomal  targeting  signals  (PTS1  and 
PTS2). 1 The PTS1  sequence is a COOH-terminal tripep- 
tide  (serine-lysine-leucine  [SKL]  or a variant)  (Gould et 
al,,  1989),  while  the  PTS2  sequence is  an  NH2-terminal 
peptide (Swinkels et al., 1991; Osumi et al., 1991). Both se- 
quences are necessary and sufficient for peroxisomal tar- 
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geting and  are used by evolutionarily diverse organisms 
(Subramani, 1993). 
Peroxisomes are intimately involved with many impor- 
tant  biochemical pathways (Van den Bosch et al.,  1992; 
Mannaerts and Van Veldhoven, 1993) and a variety of dis- 
eases in humans  (Lazarow and Moser, 1989; Wanders et 
al., 1988). One class of these disorders (group A) is charac- 
terized  by  a  generalized  loss  of peroxisomal  functions. 
Diseases  belonging  to  this  class  include  the  cerebro- 
hepato-renal  (Zellweger) syndrome (ZS), hyperpipecolic 
acidemia  (HPA), the  neonatal  form of adrenoleukodys- 
trophy (nALD)  and  infantile  Refsum's disease. Patients 
suffering from ZS  are  clinically  characterized  by severe 
craniofacial  dysmorphisms,  hypotonia,  seizures,  hepato- 
megaly, renal cysts,  and adrenal atrophy. They often die 
within a year after birth, nALD, HPA, and infantile Ref- 
sum's disease are also lethal disorders, but present them- 
selves more  mildly,  resulting  in  a  somewhat  longer  life 
span (Wanders et al., 1988). 
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placed into nine complementation groups (see Shimozawa 
et al., 1993 for an overview). All cells contain peroxisome 
ghosts  (Santos  et.  al.,  1988a,b;  Wiemer et  al.,  1989).  At 
least six complementation groups exhibit a  deficiency in 
the  import  of PTSl-containing  proteins  (Walton  et  al., 
1992;  Wendland  and  Subramani,  1993b;  Motley  et  al., 
1994). The genes affected in two of the nine complementa- 
tion groups have been identified, and encode integral per- 
oxisomal membrane proteins (PMPs) (Gartner et al., 1992; 
Shimozawa et  al.,  1992),  but the molecular basis of the 
protein-import defect in these cells remains unexplained. 
Both  genetic  and  biochemical  evidence exists  for the 
PTS1 and PTS2 pathways. The pas8 mutant of Pichia pas- 
toris (McCollum et al., 1993), the paslO mutant of Saccha- 
romyces cerevisiae (Van der Leij et al.,  1993)  and fibro- 
blasts from a patient with neonatal adrenoleukodystrophy 
(Motley et al., 1994) are selectively deficient in the PTS1- 
pathway,  but  not  the  PTS2-pathway  of  import.  Con- 
versely, the pas7 mutant of S. cerevisiae (Kunau and Har- 
tig, 1992; Marzoich et al., 1994) and patients suffering from 
the rhizomelic form of chondrodysplasia punctata (Motley 
et al., 1994) are deficient only in the PTS2-pathway of im- 
port. 
Cloning  and  characterization  of the P. pastoris  PAS8 
gene reveal that the protein it encodes is the PTS1 recep- 
tor (McCollum et al., 1993; Terlecky et al., 1995). Because 
of its central role in the import of PTSl-containing  pro- 
teins,  and  the  impairment  of this  pathway of import  in 
many of the group A peroxisomal disorders, we undertook 
the cloning of the human homologue (PTS1R) of the P. 
pastoris PAS8 gene. We describe the role of the human 
PTS1R protein in the PTSl-pathway of peroxisomal pro- 
tein import, and in correcting this protein import defect in 
two fatal peroxisomal disorders (ZS and nALD). 
Materials and Methods 
Strains, Cell Lines, and Culture Conditions 
Transformation and culture conditions of the methylotrophic yeast Pichia 
pastoris were essentially performed as described by Gould et aL (1992). 
Standard rich medium for growth of P. pastoris was YPD medium (1% 
yeast extract, 2% bactopeptone, 2% glucose). Defined synthetic medium 
(S) consisted of yeast nitrogen base at 6.7 g/l supplemented with carbon 
sources to a final concentration of either 2% glucose (SD), 0.5% methanol 
(SM), or 0.2% oleic acid/0.02% Tween-40 (SOT). Arginine was added as 
needed to a final concentration of 50 ixg/ml. Solid media were prepared by 
adding 2% bactoagar before autoclaving. The P. pastoris pus8-1  mutant 
has been characterized by McCollum et al. (1993). 
Cultured human skin fibroblasts were obtained from patients with ZS 
(cell lines FAIR-T  and  GM4340-T,  complementation groups two  and 
four,  respectively); nALD  (cell  line  ALA-T,  complementation group 
two); HPA (cell line GM3605-T, complementation group one). The cell 
lines PUCK and BAS-T were used as controls, and not derived from pa- 
tients with peroxisomal disorders. All cell lines, except the control cell line 
PUCK, were immortalized by transfection with pRSV-SV40T and selec- 
tion  for  loci  (see  Wendland  and  Subramani,  1993b).  The  cell  lines 
GM3605  and GM4340 were obtained from the Human Mutant Cell Cul- 
ture Repository (Camden, NJ); the other cell lines were obtained from 
Drs. Ann and Hugo Moser (Kennedy Krieger Institute, Baltimore, MD). 
The complementation group designation is as published by Roscher et al. 
(1989). For a standardization of the complementation grouping of peroxi- 
some-deficient  disorders see Shimozawa et al. (1993). CHO, CV1, HepG2 
cells are from American Type Culture Collection (Rockville, MD). 
Autopsy Material 
Liver samples from two patients with  ZS  (unknown complementation 
group) and from two controls were kindly supplied by Dr. Hugo Moser. 
Liver homogenates were prepared as described by Krisans et al. (1994). 
Antibodies 
Anti-PTSIR antibodies were raised as follows: a HindII-partial BamHI 
(nucleotides 663-1847)  fragment was cloned into the filled-in EcoRI site 
of the pGEX-KG polylinker (Guan and Dixon, 1991). The glutathione-S- 
transferase (GST)-PTSIR fusion protein was overexpressed in Escheri- 
chia coli DH5ct as described by Guan and Dixon (1991)  except that no 
benzamidin was used and the cells were lysed by sonication. The fusion 
protein proved to be insoluble and mostly was recovered in the pellet after 
the bacterial lysate was centrifuged at 10,000 g for 10 rain at 4°C. The in- 
soluble fraction was dissolved in protein sample buffer and subjected to 
SDS-PAGE. The GST-PTS1R fusion protein was electroeluted from the 
gel and dialyzed against PBS and subsequently thrombin buffer (50 mM 
Tris-C1, pH 8.0, 150 mM NaC1; 2.5 mM CaC12 and 0.1% [vol/vol]  13-mer- 
captoethanol) for 24 h at room temperature. The GST part of the fusion 
protein was cleaved off by a thrombin digest. The proteolytic fragments 
were separated on SDS-PAGE. The 45-kD PTS1R fragment was electro- 
eluted and used to immunize a rabbit. 
A rabbit polyclonal antiserum against rat liver 3-ketoacyl-Coenzyme A 
thiolase and a guinea pig polyclonal anti-SKL serum were a gift from Dr. 
R.  Rachubinski  (University of Alberta,  Edmonton, Alberta,  Canada). 
Anti-PMP70 was prepared in a rabbit and guinea pig using a PMP70 pep- 
tide conjugated to human serum albumin (HSA) as described by Kamijo 
et al. (1990).  A  rabbit antiserum raised against an SKL-peptide was pre- 
pared as described by Gould et al. (1990).  A  polyclonal rabbit antiserum 
was generated against bovine catalase. Polyclonal rabbit and guinea pig 
antisera directed against HSA were purchased from ICN Biomedicals, 
Inc. (Costa Mesa, CA). Species-specific anti-Ig antibodies conjugated to 
FITC or rhodamine were obtained from Jackson ImmunoResearch Labo- 
ratories, Inc. (West Grove, PA). 
Cloning and Sequencing of the PTSIR Gene 
A  partial cDNA encoding PTS1R  (nucleotides 441-3075)  was inadver- 
tently isolated while screening a human liver cDNA expression library in 
kgtll  (Clontech Laboratories, Inc., Palo  Alto, CA)  for cell adhesion- 
related proteins using a monoclonal antibody against 13-catenin. To facili- 
tate DNA sequencing, a set of nested deletions was generated by exo- 
nuclease  III.  Both  strands  of  the  resulting  overlapping  clones  were 
sequenced. The 5'end of the cDNA was cloned by reverse transcriptase- 
PCR (RT-PCR), essentially according to Frohman (1990).  Poly(A  ÷) hu- 
man liver mRNA (Clontech Laboratories, Inc.) was used as template in the 
reverse transcriptase reaction in combination with the gene specific primer 
5'GTGAACTGGTCAACCCAGGC  (nucleotides 674-655).  The  5'end 
of PTS1R was PCR amplified using a second, nested, gene-specific  primer 
5'CAGCGATCGGTGGCTGTTCC  (nucleotides 551-532)  and  the an- 
chor  primer  5'GACTCGAGTCGACATCGAT17.  The  PCR  fragment 
was cloned into the pCRTMII cloning vector (Invitrogen, San Diego, CA). 
Both strands were sequenced. A  full-length PTSIR construct was pre- 
pared in pBSKSII (Stratagene, Inc. La Jolla, CA) creating pBS-PTS1R. 
PTSIR Plasmid Constructs 
An NcoI-BgllI (nucleotides -2-2050) fragment was isolated from pBS- 
PTSIR and the NcoI site overlapping the translation start codon was filled 
in using Klenow polymerase thereby restoring the ATG. The fragment, 
which encompasses the complete FTS1R  coding sequence, was cloned 
into the Sinai and BglII polylinker sites of the mammalian expression 
plasmid p J71) under the control of the cytomegalovirus promoter (Mor- 
gensteru and Land, 1990). The resulting pJ7f~-PTSIR was used in the nu- 
clear microinjection and transfection experiments. 
A  HindII-BglII (nucleotides 663-2050) fragment was cloned m-frame 
into the filled-in EcoRI site of the T7 RNA polymerase/promoter plasmid 
pT7-7  (S.  Tabor,  Harvard  Medical School, Boston, MA)  thus creating 
pT7-7-PTS1R. In vitro transcription/translation of this construct produces 
a truncated PTSIR missing the NHE-termina1221 amino acids. 
A  PAS8-PTS1R fusion construct was assembled in pSG464 (Gould et 
al., 1992) under control of the P. pastoris PAS8 promoter. The fusion pro- 
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COOH-termina1306 amino acids of PTS1R. 
Northern Blot Analysis 
A Northern blot, containing poly(A  ÷) RNA from multiple human tissues, 
was purchased from Clontech Laboratories, Inc. and used according to the 
recommendations of the manufacturer. A HindlI-XhoI (nucleotides 663- 
1534) fragment from PTS1R was uniformly labeled with [cta2p]dCTP and 
used as a probe. Subsequently the blot was stripped and reincubated with 
a radioactively labeled human [3-actin cDNA probe. 
PAGE, Immunoblotting, Peroxisomal Membrane 
Preparations, Protein Concentration Measurements 
PAGE in the presence of SDS was carded out essentially as described by 
Laemmli (1970) and Western blotting to nitrocellulose filters according to 
Towbin et al.  (1979).  Remaining protein binding sites were saturated by 
incubating the filters for 1 h  in PBS pH 7.4  containing 0.05%  (vol/vol) 
Tween 20  (PBS-Tween)  and  5%  (wtlvol)  lowfat milk  powder. Subse- 
quently the filters were incubated with antisera diluted in the same solu- 
tion. Bound antibody was detected by incubation with a 1/5,000 dilution of 
goat anti-rabbit Ig conjugated to alkaline phosphatase (Bio-Rad Labora- 
tories, Richmond, CA). 
The one-step carbonate procedure as described by Fujiki et al. (1982) 
was used to prepare a membranous fraction containing only integral mem- 
brane proteins. In brief, highly purified rat liver peroxisomes were diluted 
at least 16-fold with 0.1 M Na2CO3, pH 11.5, to a final protein concentra- 
tion of 1.15 mg/ml, incubated on ice for 90 min, and centrifuged for 90 min 
at 100,000 g, yielding a membrane pellet and a soluble fraction. 
Protein concentration was determined according to Smith et al. (1985). 
Cell Fractionation and Isolation 
of  Rat Liver Peroxisomes 
The experiments were performed with male Sprague-Dawley rats (180- 
240 g) that were fed a standard diet. Rats were fasted for 20 h before being 
killed. Liver homogenates were prepared and fractionated by differential 
centrifugation as described by Keller et al. (1986). A rat liver "light mito- 
chondrial'" fraction (X-fraction) enriched in peroxisomes was further frac- 
tionated on a linear Nycodenz (Nycomed Pharma AS, Oslo, Norway) gra- 
dient as described by Keller et al.  (1986).  The characterization of the 
various gradient fractions for the activity of organellar marker enzymes, 
protein content, and the computer analysis of the data were performed es- 
sentially as described by Keller et al. (1986). 
In Vitro Import in Semi-permeabilized ClIO Cells 
An in vitro import assay was performed using streptolysin-O (0.2 U/mi) 
permeabilized CHO cells and 50 p,g/mi HSA-SKL as a substrate (Wand- 
land and Subramani, 1993a). Import was assessed by immunofluorescence 
microscopy with polyclonal antisera. HSA was detected using a  rabbit 
anti-HSA serum at a 1:250 dilution. For double labeling, guinea pig anti- 
HSA and rabbit anti-catalase antisera were used at a 1:500 and l:100 dilu- 
tion, respectively. Bound primary antibodies were detected by FITC- and 
rhodamine-conjugated secondary antibodies. For experiments involving 
inhibition of import, 60-lxl reactions were supplemented with 5 p,l of anti- 
PTS1R  serum  or preimmune serum.  IgG fractions were purified from 
anti-PTS1R or nonspecific sera by protein A  chromatography (Harlow 
and Lane, 1988) and used in import reactions at 1.5 I~g/pJ. 
Immunofluorescence Microscopy 
Immunofluorescence microscopy was essentially performed as described 
by Keller et al. (1987). Cultured skin fibroblasts were permeabilized selec- 
tively by digitonin as described by Swinkels et al. (1991). 
PTSIR Binding Studies 
The  SKL peptide (CRYHLKPLQSKL)  and the ASKL peptide  (CRY- 
HLKPLQ) were coupled to Affigel 102 (Bio-Rad Laboratories) via the 
NH2-terminal cysteines on the peptides, according to the manufacturer's 
specifications. 15 ~1 of in vitro translated PTS1R protein were mixed with 
35 }xl of binding buffer (20 mM Hepes, pH 7.3, 110 mM potassium acetate, 
5 mM sodium acetate, 2 mM magnesium acetate, i mM EGTA, and 2 mM 
DTT) which was then added to a 50-}xl vol of bead conjugate and incu- 
bated for 1 h at room temperature with frequent mixing. In peptide com- 
petition experiments 2  }xg and 10 I~g of each of the following peptides: 
SKL peptide, ASKL peptide, and LKS peptide (CRYHLKPLQLKS) were 
added to the incubation. The supernatant, containing unbound PTS1R 
protein, was removed and saved. The beads were washed five times with 1 
ml of binding buffer and then suspended in 50 ~1 of binding buffer. SDS- 
PAGE sample buffer was added to the fractions containing bound (beads) 
and unbound PTS1R, heated to 100°C for 5 rain, and equivalent fractions 
of the supernatant and beads were subjected to SDS-PAGE. The distribu- 
tion of PTS1R was examined by fluorography and the signals quantified 
by exposing the gels to a Phosphorimager screen (Molecular Dynamics, 
Inc., Sunnyvale, CA). All solutions used in the binding assay contained 
the following protease inhibitors: 5 p~g/ml aprotinin, 2.5 ~g/ml leupeptin, 
and 0.2 mM PMSF. 
Somatic Cell Hybrid Panel and PCR Amplifications 
We used a mapping panel of 16 human  ×  Chinese hamster hybrid cell 
lines containing overlapping sets of human chromosomes for primary as- 
signment of the PTS1 receptor gene to a human chromosome. Two hybrid 
cell lines with partial deletions of chromosome 12 were used for regional 
mapping (summarized in Francke et al., 1986). Genomic DNAs from the 
panel were amplified using PTS1  receptor-specific primers designed from 
the 3'untranslated region of the gene. The forward primer was 5'-CGC- 
CTCTAATGTCTGTCTGGATGG  (nucleotides 2247-2271)  and the re- 
verse primer 5'-TTCCAATGCTCTCCCCTAGAAAC (nucleotides 2787- 
2765),  the amplification product was 541 bp in size. The PCR conditions 
were 95°C, 5 rain; then 35 cycles of 94°C, 1 rain; 55°C, 1 min; 72°C, 1 min; 
followed by 72°C, 7 min. 
Fluorescence In Situ Hybridization (FISH) 
FISH on chromosomes was performed as described (Milatovich et al., 
1991).  Briefly, a  eDNA clone containing a  2.4-kb  insert of the human 
PTS1  receptor gene in pUC18 was labeled with biotin-16-dUTP by nick- 
translation  using  commercial reagents  (Boehringer Mannheim,  Mann- 
heim, Germany). Labeled eDNA probe was hybridized at a concentration 
of 400 ng/50 I~1 per slide to pretreated and denatured metaphase chromo- 
somes from a human peripheral blood lymphocyte culture in the presence 
of sheared unlabeled salmon sperm DNA and human placental DNA as 
competitors.  The  slides  were  incubated  at  37°C  overnight  and  then 
washed and reacted with avidin/FITC (Vector Laboratories, Inc., Burlin- 
game, CA). Hybridization signals were amplified by treatment with bioti- 
nylated goat anti-avidin D antibody (Vector Laboratories, Inc.) followed 
by another round of incubation with avidin/FITC.  Chromosomes were 
counterstained with propidium iodide. At least 20  metaphase chromo- 
somes were  analyzed under  an  epifluorescence microscope (Axiophot, 
Carl Zeiss, Inc., Thornwood, NY), and images were collected with a CCD 
camera as described (Li et al., 1994). Hybridization signals were consid- 
ered as specific only when the fluorescent signal was observed on both 
chromatids of a chromosome. 
Microinjection 
ALA-T, FAIR-T, and GM4340-T cells were microinjected with purified 
plasmid DNA (15-150 copies/ceU) using a  semiautomatic microinjector 
and manipulator (Eppendorf North America, Inc., Madison, WI) with an 
inverted microscope (Carl Zeiss, Inc.). Each expression vector (0.01 mg/ 
ml) was injected directly into the nuclei of at least 200 ceils along with 
guinea  pig  IgG  (10  mg/ml)  marker  antibody in  100  mM  KC1,  5  mM 
Na2PO4, pH 7.4. 6 h after injection, cells were fixed in 3.7% formaldehyde 
and further processed for immunofluorescence essentially as described by 
Keller et al.  (1987)  except that the fixed cells were permeabilized by a 
0.3%  (vol/vol) Triton X-100 solution in PBS for 15 min after which the 
cells were washed four times with PBS and incubated with the appropriate 
antiserum dilutions made up in PBS containing 0.5% (vol/vol) NP-40 and 
5  mg/ml BSA. The subcellular localization of SKL-containing proteins 
was examined, by a first step incubation with a rabbit anti-SKL antiserum 
followed by a second incubation with anti-rabbit Ig rhodamine. Injected 
cells were identified by anti-guinea pig Ig FITC. 
Mammalian Transfection 
ALA-T and FAIR-T cells were grown on glass coverslips and transfected 
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and Stark (1979). 
Results 
The Human PTS1R Is Homologous to the Yeast 
PTS1 Receptor 
We cloned and sequenced a human cDNA that encodes a 
protein of 602 amino acids with an estimated molecular 
mass of 67 kD and isoelectric point of 4.2. The sequence 
(EMBL accession number Z48054) is likely to represent 
the full-length cDNA. When the 5'end was cloned by RT- 
PCR, several PCR fragments were cloned that differed in 
length at their 5'ends. In the shorter clones that ended at 
positions -64 and  -83, a G  was found directly following 
the anchor primer. We believe these G's, which were ab- 
sent in longer clones extending to -85, are derived from 
the cap structure of the full-length mRNA (Hirzmann et 
al.,  1993).  In  extensive  attempts  to  clone additional  se- 
quence at the 5' end, using reverse transcriptase-PCR with 
a set of nested oligonucleotides hybridizing to the extreme 
5'  end of the sequence, no longer clones were obtained. 
The first ATG encountered in the sequence (position 1-3) 
is most likely used as the start codon. Together with its 
flanking  sequences  it  fits  the  consensus  for  an  optimal 
translation start site (Kozak, 1984). Translation of the pu- 
tative full-length cDNA in vitro produces a  protein that 
migrates at a similar molecular weight in a SDS-polyacryl- 
amide gel as the PTS1R protein in rat liver homogenates 
identified by a specific antiserum against PTS1R (Fig. 1). 
Finally,  an  expression construct starting  with  this  ATG 
was able to complement the primary defect in group two 
peroxisomal disorders (see below). 
The amino acid sequence defines the PTS1R protein as 
a  member of the tetratricopeptide repeat (TPR) protein 
family to which proteins with diverse functions (chromo- 
some segregation, cell cycle control, mitochondrial import, 
and transcription) belong (Goebl and Yanagida, 1991). A 
Figure 1.  In vitro translated PTSIR 
comigrates  with  rat  liver  PTS1R. 
Radiolabeled  full-length  PTS1R, 
prepared by in vitro transcription- 
translation  reactions,  was  mixed 
with a rat liver extract, correspond- 
ing to 100 I~g total protein, and sub- 
jected to SDS-PAGE. Proteins were 
transferred to nitrocellulose and the 
[35S]methionine-labeled PTS1R de- 
tected by autoradiography  (lane 1). 
The blot was  then incubated  with 
anti-PTS1R  serum  to visualize the 
PTS1R present in the rat liver ho- 
mogenate (lane 2). Molecular mass 
markers  (kD) are indicated  on the 
left. 
database search using the BLAST program and the PTS1R 
protein sequence as query detected a strong similarity with 
the P. pastoris  PAS8 and S. cerevisiae PAS10 proteins. A 
number of other proteins belonging to the TPR protein 
family  like  nuc2  ÷,  BimA,  CDC16,  CDC23,  STI1,  and 
SSN6 were also found, but their similarity with the TPR 
domain of PTS1R was rather limited and fragmentary. 
Alignment of the PTS1R primary amino acid sequence 
with the P. pastoris  PAS8 protein and its homolog the S. 
cerevisiae PAS10 protein reveals the high degree of simi- 
larity  (55.1  and  50.5%,  respectively) with both proteins 
(Fig.  2).  The  overall  identity  between  PTS1R  versus 
PpPAS8 and ScPAS10 is 33.9 and 27%, respectively. The 
overall similarity and identity are not much higher when 
only PpPAS8 and ScPAS10 are compared (61.8 and 41%, 
respectively). The similarity is most striking in the TPR 
domain of the proteins and less so in their NH2-terminal 
parts. Not all TPR repeats are equally well conserved, in 
particular repeats three and four, corresponding to amino 
acid  residues  366--450,  show  poor  similarity.  It  is  most 
likely  that  PTS1R,  PpPAS8,  and  ScPAS10  are  homo- 
logues. 
Since it was demonstrated that the TPR domain of P. 
pastoris PAS8 binds the PTS1 (SKL) peptide (Terlecky et 
al., 1995) the ability of a PAS8-PTSIR fusion protein (the 
NH2-terminal part of PAS8p linked to the TPR domain of 
PTS1 R) to complement the P. pastoris pas8-1 mutant pro- 
vides a stringent test of PTS1R function in yeast. Table I 
shows that a differential complementation was observed, 
i.e.,  expression  of the  PAS8-PTS1R fusion restored  the 
ability of the pas8-1 mutant to grow on media containing 
oleate as sole C-source, however, it did not restore the abil- 
ity to metabolize methanol. 
PTS1R is Expressed in Various Human Tissues 
A single hybridizing band of ~3.4 kb, similar to the cDNA 
length,  was  observed when  a  Northern  blot  containing 
poly(A  +) mRNAs from several human tissues was hybrid- 
ized with a PTS1R probe (Fig. 3). The lower panel of Fig. 
3 shows the same blot which, after stripping, was reprobed 
with a  human  ~-actin cDNA probe. A  variability in the 
level of PTS1R expression can be  observed, however it 
cannot be unequivocally determined whether these varia- 
tions are significant or are caused by the different amounts 
of RNA loaded onto the blot. 
Assignment of PTS1R Gene to Chromosome 
Band 12p13.3 
With primers complementary to 3'untranslated region se- 
quences  of the  PTSIR  gene  the  expected 541-bp  PCR 
product was  amplified from total human  genomic DNA 
but not from hamster DNA. The specific PCR product was 
also obtained from human x  Chinese hamster hybrid cell 
lines that had retained human chromosome 12. All other 
human chromosomes were excluded by the presence of at 
least three discordant hybrid cell lines (Table II). Further- 
more, two hybrid cell lines retaining different partially de- 
leted  copies  of chromosome  12  were  used  for regional 
mapping.  Positive PCR  amplification was  observed in  a 
hybrid cell line  containing region  12pter-q21  but not in 
one  containing  only  the  long  arm,  region  12cen-qter. 
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HsPTSIR  MAMRELVEAE  CGGANPLMKL  AGHFTQDKAL 
PpPAS8  MSLIGGGSDC  AAGSNPLAQF  TKHTQHDTSL 
ScPASI0  ...MDVGS.C  SVGNNPLAQL  HKHTQQNKSL 
*  ***  *  * 
51 
HsPTSIR  SKPLGVASED  ELVAEFLQDQ  NAPLVSRAP. 
PpPAS8  ESTMSPMERQ  Q.MDQFMQQQ  NNPAFNFQPM 
ScPASI0  KPGISEAFIS  N.VNAISQE  ...... NMANM 
98 
HsPTSIR  ........... NFRQAPQRA  PGVADLALSE 
PpPAS8  NNSWNQEFRM  KDPMVANAPS  AQVQTPVQST 
ScPASI0  SSGRLPPFSN  VHSLQTSANP  TQIKGVIkrDIS 
HsPTSIR 
PpPAS  8 
ScPASI0  NSEKAWQRGS 
168 
HsPTSIR  EEKLWLGEPE 
PpPAS8  PAQAQTS.. E 
ScPASI0  SGRSKEGVNE 
218 
HsPTSIR  DAWVDQFTRP 
PpPAS8  SM.  LNSKTQE 
ScPASI0  SE.  VEQNKPE 
268 
HsPTSIR  AHPWLSDYDD 
PpPAS8  NRPVSGSMGE 
ScPASI0  NDDL..NLGE 
312 
HsPTSIR  G.  DLPNAVLL 
PpPAS8  GAKLSEAGLA 
ScPASI0  GAKLSEAALA 
361 
HsPTSIR  LKPDNOTALM 
PpPAS8  LDPTNLAALM 
ScPASI0  LDPKNLEAMK 
411 
HsPTSIR  GGAGLQPSKR 
PpPAS  8  PDLD...  GGD 
Sc  PAS  10  DKFQKEKGFT 
459 
HsPTSIR  VLFNLSGEYD 
PpPAS8  VLFYSMEEFD 
ScPASI0  LLFYTKDDFD 
5O9 
HsPTSIR  RRALELOPGY 
PpPAS8  SRALQLNPNF 
ScPASI0  HRALQLKPSF 
***  *  * 
554 
HsPTSIR  GPRGEGGAMS 
PpPAS8  EMSSNQGLQN 
ScPASI0  DVGSLLNTYN 
137 
ETDWS  ...................  QEFISE 
QHPILSVPGV  RAG  .............. IYG 
TTASSRFQYP  NTMMNNYAYA 
GTATDRWYDE  YHPEEDLQHT 
QSQTQW  ....... EDQFKDI 
QEQQPW  ....... TDQFEKL 
VNTSALDMEF  ERAKSAIESD 
PKTKQQE  ...... QNTFE.. 
TVEKEEGVYG  DQYQSDFQ.. 
RQEGLRPGPW  PPGAPASEAA 
.QQSMRNGEF  QQGNQRMMRN 
.QFNQKNNGR  LNESPLQGTN 
.QTFKMDDLL  AEMQQIEQS. 
QHELNV..MQ  QNMNAPQQVA 
QRFINGEPLI  DDKRRMEIGP 
NWAQEFLAAG  DAVDVTQDYN 
NWAQDFQQAG  PEVQHHAQQH 
HWSQEFQGSN  S  IQNRNADTG 
VTDPLSVSPA  RWAEEYLEQS 
GGRLMGGSMM  NRAAQMQQQN 
SMNSLSGSRL  QSPAFMNQQQ 
ASDFVAKVDD  PKLANSEGTS 
m  ................... 
EKEVSENLDI  NDEIEKEENV 
VDFWDKLQAE  LEEMAKRDAE 
.QVWDDIQVS  YADV...ELT 
.EVWDSIHKD  AEEVLPSELV 
......  LTSA TYDKGYQFEE  ENPLRDHPOP  FEEGLRRLOE 
RFCPIRRRRL  NYG.EYKYEE  KNQFRNDPDA  YEIGMRLMES 
DYLKYLGGRV  NGNIEYAFQS  NNEYFNNPNA  YKIGCLLMEN 
FEAAVOODPK  HMEAWOYLGT  TOAENEOELL  AISALI~RCLE 
FEAAVQQDPK  HVDAWLKLGE  VQTQNEKESD  GIAALEKCLE 
FEAAVKEKPD  HVDAWLRLGL  VQTQNEKELN  GISALEECLK 
*****  *  *  **  **  *  **  *  *  **  ** 
ALAVSFTNES  LOROACETLR 
TLAISYINDG  YDNAAYATLE 
TLAISYINEG  YDMSAFTMLD 
**  *  *  *  * 
DWLRYTPAYA  HLVTPAEEGA 
RWI..ETKYP  DIASRARSSN 
KWA..ETKYP  EIWSRIKQQD 
ILGSLLSDSL  FLEVKELFLA AVRL..DPTS  IDPDVOCGLG 
RIE  ......  Q  NKRVTELFMK  AAQLSPDVAS  MDADVQTGLG 
HID  ......  M  NAHITKQFL.  ..QLANNLST  IDPEIQLCLG 
*  *  *  *  ** 
KAVDCFTAAL  SVRPNDYLLW  NKLGATLANG  NOSEEAVAAY 
KTIDCFKAAI  EVEPDKALNW  NRLGAALANY  NKPEEAVEAY 
KTIDCFESAL  RVNPNDELMW  NRLGASLANS  NRSEEAIQAY 
*  ***  **  *  *  *  *  *  ***  ***  *  ***  ** 
IRSRYNLGIS  CINLGAHREA 
VRARYNLGVS  FINMGRYKEA 
VRARYNLAVS  SMNIGCFKEA 
*  ****  *  *  *  ** 
ENIWSTLRLA  LSMLGQSDAY 
NALVETLKRA  FLGMNRRDLV 
DTVIETLKRV  FIAMNRDDLL 
VEHFLEALNM  Q .....  RKSR 
VEHLLTGISL  HEVEGVD.  AS 
AGYLLSVLSM  HEVNTNNKKG 
GAA.  DARDLS  TLLTMFGLPQ 
DKVYPGMGLA  QFRKMFDF 
QEVKPGMDLK  RFKGEFSF 
These results indicate  that the PTS1R gene is located on 
the short arm of chromosome 12 (Fig. 4). 
FISH  using  a  PTS1R  cDNA  clone  as probe  indepen- 
dently  confirmed  the  result  from  the  hybrid  mapping 
panel.  Of 21 metaphase spreads analyzed, 16 exhibited a 
specific fluorescent signal at band p13.3 on both chroma- 
tids  of a  chromosome 12,  and in  9  of these  cells  signals 
were  found  on  both  chromosome  12  homologues.  The 
Figure 2.  Sequence alignment between the hu- 
man  PTS1R  (HsPTS1R), P.  pastoris PAS8 
(PpPAS8), and S. cerevisiae PAS10 (ScPASIO) 
using the PILEUP program. Identical residues 
are  indicated  by  an  asterisk below  the  se- 
quence. The TPR domain of PTS1R is under- 
lined. These sequence  data are available from 
EMBL/GenBank/DDBJ  under accession num- 
ber ZA8054. 
chromosomes were identified based on an R banding pat- 
tern produced by the incorporation of bromodeoxyuridine 
after synchronization of the cells (Fig. 4). 
PTS1R Expression in Tissues and Mammalian 
Cell Lines 
An  immunoblot,  containing  total  protein  fractions  from 
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Mutant by PAS8-PTSI R Fusion Construct 
Construct  SM (OD6co)  SOT/Yeast extract (OD600) 
pSG464  0.051 (n = 3)  0.431 (n =  3) 
pSG464-PAS8  1.352 (n = 2)  1.311 (n = 2) 
pSG464-PAS8-PTS1R  0.050 (n =  12)  1.142 (n =  12) 
The P. pastoris mutant pas8-1  (McCollum et al.,  1993) was transformed by elec- 
troporation with the vector pSG464 (Gould et al., 1992) containing no insert, the com- 
plete PAS8 coding sequence, or a PAS8-PTS 1R fusion construct. Arg-positive colo- 
nies were picked and grown overmght in YPD after which the ceils were harvested, 
washed, and used as inoculum for SM or SOT/YE and allowed to grow for 48--72 h. 
Subsequently ahquots of the yeast cultures were harvested, washed, and resuspended 
in an equal volume of H20  Growth was assessed by determining the OD600.  Depicted 
are average values of a number of independent cultures. Note that the SOT medium 
was supplemented with 0.1% yeast extract explaining the growth observed in the 
pSG464 transformants. It was verified that a construct consisting of the NH2-terminal 
half of PAS8p did nut complement the pas8-1 mutant for growth on oleate or meth- 
anol. 
rat liver and human liver homogenates, revealed one ma- 
jor protein of 80 kD that was recognized by an anti-PTS1R 
serum (Fig. 5 A, lanes/-4). The apparent discrepancy be- 
tween  the  predicted molecular mass  of PTS1R  (67  kD) 
and  the  immunologically identified  protein  can  be  ex- 
plained by assuming that PTS1R migrates aberrantly on 
SDS-polyacrylamide gels.  Indeed  in  subsequent  experi- 
ments we showed that in vitro translated PTS1R comigrates 
with the 80-kD protein that is recognized by the antiserum 
(Fig. 1), identifying this protein as PTS1R. The 80-kD pro- 
tein  did not  seem to be  induced  significantly when rats 
were treated with the hypolipidemic drug clofibrate, which 
is known to cause induction of the peroxisomal 13-oxida- 
tion system and peroxisomal proliferation (Fig. 5 A, com- 
pare lanes 1  and 2). However, the protein was absent or 
markedly reduced in the two liver homogenates from ZS 
patients (Fig. 5 A, lanes 5 and 6) indicating that the 80-kD 
protein is indeed related to the peroxisomal compartment. 
Nonspecific proteolytic breakdown of the Zellweger au- 
topsy liver material as an explanation for the absence of 
PTS1R is unlikely as the Ponceau S staining profile after 
blotting revealed no general protein degradation. Further- 
Figure 3.  Expression  of the 
PTS1R  gene in  various  hu- 
man tissues. A  multiple  hu- 
man  tissue  Northern  blot 
contains ~2 I~g of poly(A  ÷) 
RNA  per  lane  from  heart 
(lane 1); brain  (lane 2); pla- 
centa (lane 3); lung (lane 4); 
liver (lane 5); skeletal muscle 
(lane 6); kidney (lane 7); and 
pancreas  (lane  8).  The  top 
panel  shows the  blot  incu- 
bated with a PTS1R-specific 
probe,  the  bottom  panel 
shows  the  blot  incubated 
with a control human B-actin 
cDNA probe. A 2-kb [3-actin 
mRNA  was  observed  in  all 
lanes and in heart and skele- 
tal  muscle  an  additional 
smaller mRNA of 1.6-1.8 kb 
representing  a 13-actin isoform that is expressed in these tissues. 
Markers in kilobases are depicted on the left. 
more, an immunoblot incubated with anticatalase demon- 
strated that catalase was present in normal quantities in 
the Zellweger liver samples (data not shown). 
PTS1R was present, and could be detected as a  major 
band (Fig. 5 B, cf. lane 1 with lanes 2-5) by our antiserum, 
in whole cell lysates of various cultured cell lines derived 
from humans, monkey, and Chinese hamster. In most pa- 
tient fibroblast cell lines PTSIR was present in normal or 
nearly normal quantities  (Fig.  5 B, compare lane 5  with 
lanes 6, 7, and 9). However, in one Zellweger patient cell 
line, FAIR-T (Fig. 5 B, lane 8), belonging to complemen- 
tation group two, the protein was  absent.  Note that the 
cells derived from an nALD patient ALA-T (Fig. 5 B, lane 
7)  belonging  to  the  same  complementation  group  con- 
tained a PTS1R protein of the normal size. 
PTSIR is Largely Cytosolic but Partly Localized 
to the Peroxisomal Compartment 
A  rat  liver homogenate was  fractionated by differential 
centrifugation into a soluble fraction, corresponding to the 
cytosol, and an organellar or light mitochondrial (k) frac- 
tion.  The  presence  of PTS1R,  catalase,  and  3-ketoacyl- 
coenzyme A  (CoA) thiolase in both of these fractions was 
examined by immunoblotting. PTSIR was predominantly 
found in the cytosol; only a  minor amount could be de- 
tected in the organellar pellet (Fig.  6). The peroxisomal 
matrix enzymes catalase and thiolase, both known to eas- 
ily  leak  from  peroxisomes  during  fractionation,  were 
found to be distributed equally over both fractions (Fig. 
6),  corroborating  the  existence  of  a  genuine  cytosolic 
PTSIR pool. 
The organellar fraction shown in Fig. 6 was further frac- 
tionated by isopycnic centrifugation on a continuous Ny- 
codenz gradient. The gradient was characterized by mea- 
suring protein content and marker enzyme activities for 
different subcellular  organelles  (Fig.  7  A).  Peroxisomes 
peak, as judged by the distribution of catalase, in the dense 
part of the gradient (fractions 17-22), well separated from 
microsomal  and  mitochondrial  fractions  (Fig.  7  A).  A 
small part of the catalase activity was observed at the top 
of the gradient, comigrating with the cytoplasmic marker 
enzyme phosphoglucose isomerase. This represents cata- 
lase released from the peroxisomes during fractionation. 
To reproduce the distribution of different subcellular or- 
ganelles in  the gradient,  equal portions  of each fraction 
were subjected to SDS-PAGE and blotted onto nitrocellu- 
lose. The blot was incubated with the anti-PTS1R serum. 
Most of the PTSIR loaded on the gradient was present in 
the peroxisomal peak fractions (Fig. 7 B). The lower tool 
wt bands observed are most likely degradation products of 
PTS1R. A considerable trailing into the lighter part of the 
gradient  was  observed, a  phenomenon which is  not un- 
common for peroxisomal membrane or membrane-associ- 
ated proteins. The PMP70 distribution profile colocalized 
with the peroxisomes. Although the trailing was less pro- 
nounced  than  observed with  PTS1R,  some  PMP70  was 
present  in  the  mitochondrial  peak  fractions  (data  not 
shown). It might be that PTSIR, which has no clearly iden- 
tifiable membrane anchoring-domain, is released from the 
peroxisomes as they move through the gradient to their 
buoyant density. 




Signal/chromosome  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  X 
Discordant hybrids 
+/-  3  4  1  1  5  1  7  4  4  7  2  0  4  2  3  2  8  3  1  2  2  2  1 
-/+  2  1  3  2  1  4  1  4  1  1  2  0  5  6  3  2  2  3  4  1  5  4  2 
Concordant hybrids 
+/+  4  3  6  5  3  6  1  4  2  1  5  8  4  6  5  6  0  5  7  6  6  6  1 
-/-  6  7  4  6  7  4  5  3  7  7  5  8  2  2  5  4  6  5  3  7  2  3  3 
Informative hybrids  15  15  14  14  16  15  14  15  14  16  14  16  15  16  16  14  16  16  15  16  15  15  7 
Percent discordance  33  33  29  21  38  33  57  53  36  50  29  0  60  50  38  29  63  38  33  19  47  40  43 
The presence (+) or absence (-) of the PTS1R-specific  PCR product is compared to the presence (+) or absence (-) of each chromosome  in 16 independent  hybrid cell 
hnes. Data for chromosomes with  rearrangments or present at low copy number (<0.1) were  excluded.  Percent  discordance is calculated  as the sum of discordant over  total 
informalave  hybrids for each  chromosome. 
To  characterize  further  the  association  of PTSIR  with 
peroxisomes,  we  subfractionated  highly  purified  peroxi- 
somes by the one-step carbonate extraction procedure de- 
scribed  by  Fujiki  et  al.  (1982).  3-Ketoacyl-CoA  thiolase 
was confined to the soluble fraction, as expected for a  sol- 
uble  peroxisomal  matrix  protein  (Fig.  7  C).  Most  of the 
PMP70,  an  integral  membrane  protein  (Kamijo  et  al., 
1990),  was  associated with the membranous  fraction. The 
PTS1R  protein,  under  these  experimental  conditions,  ap- 
peared to be partially resistant to carbonate extraction, in- 
dicative  of  a  very tight  association  with  the  peroxisomal 
membrane.  With the PAS8 protein  in P. pastoris,  a  large 
portion  of the  protein  proved  to  be  carbonate  insoluble 
(Terlecky et al., 1995). 
Additional evidence that PTS1R, in part, has a peroxiso- 
mal localization in mammalian cells was derived from dou- 
ble-labeling immunofluorescence experiments using CHO 
Figure 4.  Chromosomal mapping of the PTS1R gene. G-banding 
ideogram of human chromosome 12 with localization of human 
PTSIR gene by somatic cell hybrid analysis (SCH) and fluores- 
cence in situ hybridization  (FISH).  Vertical bars  represent  the 
portions of chromosome 12 retained in two somatic--cell hybrid 
lines that were positive (+) or negative (-)  for the human-spe- 
cific PTS1 receptor PCR product. 
Figure 5.  Presence of PTS1R in liver homogenates and cultured 
cell  fines  from  different  organisms.  (A)  Liver  extracts,  corre- 
sponding  to  100  I~g  of  total  protein,  from  a  rat  (lane  1),  rat 
treated with the peroxisome proliferator clofibrate (lane 2), hu- 
man  (lanes 3  and 4), two unrelated  Zellweger patients  (lanes 5 
and 6) were subjected to SDS-PAGE and transferred to nitrocel- 
lulose. The blot was incubated with anti-PTS1R serum. Molecu- 
lar mass markers (kD) are indicated on the left. (B) Total cell ex- 
tracts,  corresponding  to  100  ~g of total protein,  from rat  fiver 
(lane 1), human hepatoma cells (HepG2) (lane 2), African green 
monkey kidney cells (CV1) (lane 3), CHO cells (lane 4), control 
human skin fibroblasts BAS-T (lane 5), skin fibroblasts from pa- 
tients  suffering from peroxisomal  disorders:  GM3605-T  (HPA, 
complementation group one, (lane 6), ALA-T (nALD, comple- 
mentation  group  two,  (lane  7),  FAIR-T (ZS, complementation 
group two, (lane 8), and GM4340-T (ZS, complementation group 
four, (lane 9) were subjected to SDS-PAGE and blotted onto a 
nitrocellulose flter. The blot was incubated with anti-PTSiR se- 
rum. Molecular mass markers (kD) are indicated on the left. 
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PTS1R. Distribution of PTS1R, cat- 
alase, and 3-ketoacyl-CoA thiolase 
in a  soluble (cytosolic) (S) and or- 
ganellar  (h-fraction)  fraction  (P). 
The  fractions were  prepared from 
rat liver homogenates by differen- 
tial centrifugation as  described by 
Keller et al. (1986).  Equal portions 
of both fractions (corresponding to 
79 I~g of the soluble and 23.5 txg of 
the organellar fraction) were subjected to SDS-PAGE and the 
proteins  transferred  to  nitrocellulose.  Specific  antisera  were 
used to visualize the distribution of the proteins. Only the rele- 
vant parts of the gel are shown. 
cells.  A  punctate  fluorescent  pattern  was  observed  in 
CHO cells incubated with an anti-SKL antiserum identify- 
ing the peroxisomal compartment (Fig. 7 D, a). A  similar 
pattern, which is in fact completely superimposable with 
the anti-SKL signal, was found when the anti-PTSiR sig- 
nal was observed (Fig. 7 D, b). This peroxisomal localiza- 
tion of PTS1R by immunofluorescence was observed only 
in  streptolysin-O-permeabilized  cells,  and  not  in  cells 
fixed  and  permeabilized  without  initial  streptolysin-O 
treatment.  Although  the  streptolysin-O permeabilization 
conditions do not allow all the cytosol to leak out (Wend- 
land and Subramani, 1993a), it is possible that some of the 
cytosolic PTS1R  is  released,  revealing  the  peroxisome- 
associated PTS1R more clearly. 
Figure 7.  PTSIR is in part associated with peroxisomes. (=4) Distribution profiles of the total amount of protein and marker enzyme ac- 
tivities after isopycnic centrifugation of a rat liver h-fraction on a linear Nycodenz gradient: protein (a); esterase (ER, II); glutamate de- 
hydrogenase (mitochondria, ©); phosphoglucose isomerase (cytosol, [3); catalase (peroxisomes, 0). The ordinate, relative concentra- 
tion (C/C  0, is derived by dividing the actual concentration of the enzyme in a particular fraction by the concentration of the enzyme that 
would be observed if the enzyme were homogeneously distributed throughout the gradient. The abscissa is the normalized cumulative 
volume (the total volume was 31 ml); the area of each graph is thus 1. Density of gradient increases from left to right. (B) Detection of 
PTS1R in different rat liver subcellular fractions. Proteins present in the fractions, characterized in A, were separated by SDS-PAGE 
and transferred electrophoretically to nitrocellulose filters. The blot was subsequently incubated with anti-PTS1R. Molecular mass 
markers (kD) are indicated on the left. (C) Distribution of PTS1R, PMP70 and 3-ketoacyl-CoA thiolase in carbonate-extracted mem- 
branes and carbonate-soluble fraction of isolated rat liver peroxisomes. Highly purified peroxisomes were treated with 0.1 M Na2CO  3 
(pH 11.5) for 90 rain at 0°C. After centrifugation a membrane pellet and a soluble fraction were obtained. Equal parts of the membrane 
fraction (P) and soluble fraction (S) (proteins of the carbonate soluble fraction were concentrated by trichloroacetic acid precipitation) 
were subjected to SDS-PAGE, blotted to nitrocellulose filters and incubated with anti-PTS1R, anti-PMP70 and anti-thiolase. Single 
bands of the expected molecular weights were detected. Only the relevant portions of the blot are shown. (D) Colocalization of PTS1R 
with SKL-containing proteins in semipermeabilized CHO cells. CHO cells were permeabilized with 0.2 U/ml streptolysin O, a condition 
in which much of the cytosol is retained in the ceils, essentially as described by Wendland and Subramani (1993a).  The semipermeabi- 
lized cells were then further processed for immunofluorescence and incubated in a first step with guinea pig anti-SKL antibody and rab- 
bit anti-PTS1R, and in a second step with anti-guinea pig Ig rhodamine (a) and anti-rabbit Ig FITC (b). 
The Journal  of Cell Biology,  Volume 130, 1995  58 Figure 8.  Anti-PTS1R antibody inhibits import of HSA-SKL into semipermeabilized CHO cells. An in vitro import assay (Wendland 
and Subramani,  1993a) was performed using streptolysin-O permeabilized CHO cells and 50 p~g/ml HSA-SKL as a substrate.  Import 
was assessed by immunofluorescence microscopy with polyclonal antisera. A and B: double labeling experiment in which permeabilized 
cells were stained with rabbit anti-catalase  (A) and guinea pig anti-HSA (B). C-F: import was performed in the presence of 5 p,1 anti- 
PTS1R serum (C), 5 Ixl preimmune serum (D), 1.5 Ixg/txl  of an anti-(PTS1R)  IgG preparation (E), or 1.5 p,g/lxl  of an unrelated IgG prep- 
aration  (F).  The uptake of HSA was  determined with  rabbit anti-HSA. Bound primary antibodies  were detected by FITC- and 
rhodamine-conjugated secondary antibodies.  Bar, 20 Ixm. 
Anti-PTS  IR Antibodies Inhibit PTS1 Import 
The ability of anti-PTS1R antibodies to interfere with the 
import of PTSl-containing proteins was tested by making 
use of an in vitro import system developed by Wendland 
and Subramani (1993a).  The system uses streptolysin-O- 
permeabilized CHO cells and is extensively characterized 
using the substrate human serum albumin conjugated with 
a peptide (CRYHLKPLQSKL) ending in the peroxisomal 
targeting sequence SKL (HSA-SKL). The uptake of HSA- 
SKL into peroxisomes can be visualized by immunofluo- 
rescence.  We  examined the  effect of anti-PTSIR on the 
uptake of HSA-SKL. 
In a  double-labeling  experiment the  HSA-SKL, under 
the conditions used, accumulated in a subcellular compart- 
ment (Fig. 8 B) which is identified as the peroxisome by its 
costaining with antibodies to catalase (Fig. 8 A). The addi- 
tion of anti-PTSiR antiserum (Fig. 8 C) or an anti-PTS1R 
IgG preparation (Fig. 8 E) to the in vitro import system 
completely abolished  the  uptake  of HSA-SKL, whereas 
the addition of preimmune serum (Fig. 8 D) or an equiva- 
lent amount of an unrelated IgG preparation had no effect 
(Fig. 8 F). These results show that PTS1R is required for 
peroxisomal  protein  import  via  the  PTS1  (SKL-depen- 
dent) pathway, consistent with its role as the PTS1 receptor. 
PTSIR Protein Binds to the SKL Targeting Signal 
Two peptides, SKL (CRYHLKPLQSKL) and ASKL (CRY- 
HLKPLQ), were covalently coupled via their NH2-termi- 
nal cysteines to agarose beads. Both the ASKL and control 
(no  peptide  coupled)  beads  bound  25%-30%  of the  in 
vitro translated PTSIR (Fig. 9 A). When SKL beads were 
used, the amount of PTS1R bound to the beads increased 
to 85%, showing that it binds specifically to the SKL tar- 
geting signal. The addition of an excess of free SKL-pep- 
tide  could compete the binding of PTS1R to SKL beads 
whereas the free ASKL or LKS (CRYHLKPLQLKS) pep- 
tides competed to a much lesser extent at similar concen- 
trations (Fig. 9 B). 
In the binding experiments we used a truncated PTS1R, 
missing 221 amino acids from its NH2-terminal end but en- 
compassing  its  TPR  domain,  as  we  know  from  similar 
studies performed with the PAS8 protein that this portion 
of the protein is involved in the binding of the PTS1 (Ter- 
lecky et al., 1995). However, comparable results were ob- 
tained when a  full-length PTS1R protein was used  (data 
not shown). 
PTSIR Restores the SKL Protein-import Deficiency 
in Fibroblasts from Patients with Fatal Peroxisomal 
Disorders Belonging to Complementation Group Two 
We  wished  to  determine  whether  a  PTS1R  deficiency 
could  cause  a  generalized  impairment  of  peroxisomal 
functions in the human group A  disorders. Complementa- 
tion group two contained two cell lines; one derived from a 
Wiemer  et al. Human  PTS1 Receptor  Complements  Peroxisomal  Disorders  59 ,v  I00 
a.  80 
o 
~  60 










~-"'  100 t 
="  80  'ID 
C 
.~  6o 
40 
m 
"  20 
S  B  S  B  S  B  a.  0 
beads  I~ads-ASKl_  beads-SKL  SKL  /~SKL  LK$ 
Figure 9.  PTS1R binds specifically to SKL-peptide. (A) The SKL peptide (CRYHLKPLQSKL) and the ASKL peptide (CRYHLKPLQ) 
were covalently coupled to Affige1102 via the NH2-terminal cysteines on the peptides. The ability of PTS1R to bind to the beads was as- 
sessed as described in the Materials and Methods section. The percent distribution  of bound (B) vs. unbound (S) PTS1R was deter- 
mined by subjecting equal amounts of the supernatant and beads to SDS-PAGE and quantitating  the amounts of radioactivity in each 
fraction using a Phosphorimager.  (B) The ability of PTS1R to bind an SKL-peptide  (CRYHLKPLQSKL), immobilized on agarose 
beads, was determined in the presence of 2 p,g (black bars) and 10 p,g (hatched bars) of the following peptides: CRYHLKPLQSKL 
(SKL), CRYHLKPLQ (ASKL) and CRYHLKPLQLKS (LKS). Depicted is the percentage of bound PTS1R, as quantified by a phos- 
phorimager, whereby the amount found to bind to SKL beads in the absence of any competing peptide was arbitrarily set at 100%. 
patient suffering from nALD  (ALA-T) and another de- 
rived from a ZS patient (FAIR-T). Both cell lines were in- 
formative with regard to PTS1R. The ALA-T cell line dis- 
played a phenotype that was reminiscent of the phenotype 
of the P. pastoris pas8 and S. cerevisiae  paslO mutants, i.e., 
catalase (Fig. 10 C), SKL-containing proteins (see Fig. 11 
compare A with B) were not present in peroxisomal struc- 
tures, however, thiolase, which has a PTS2, seemed to ac- 
cumulate in subcellular structures as judged by immuno- 
fluorescence (Fig.  10 B) (see also Motley et al.,  1994,  in 
which this cell line is referred to as AAL85AD). In con- 
trast, the FAIR-T cell line did not contain either SKL pro- 
teins (Fig. 11 C) or thiolase (Fig. 10 E) in its peroxisomal 
ghosts. Both cell lines, however, showed a comparable but 
clearly aberrant  immunofluorescence staining  with  anti- 
PMP70 (Fig. 10, A and D). 
A full-length PTS1R mammalian cDNA expression con- 
struct injected into the nuclei of ALA-T and FAIR-T re- 
stored the ability of these cells to import SKL-containing 
proteins into their peroxisomes within 6 h after injection. 
This is illustrated in Fig. 11, E and F (ALA-T) and Fig. 11, 
G and H  (FAIR-T), where E  and G identify the microin- 
jected cells stained for the presence of guinea pig antibod- 
ies that were coinjected. Sometimes the coinjected anti- 
bodies remained in the nucleus (Fig.  11  G) or dispersed 
through the cytoplasm (Fig. 11 E). The punctate fluores- 
cence signal seen in the same cells stained with rabbit anti- 
SKL antibody (Fig. 11 F, ALA-T; Fig. 11 H, FAIR-T) is 
suggestive of import of SKL-containing proteins into the 
peroxisomes.  Similar  results  were  obtained  when  the 
group two cells were transfected, using the calcium phos- 
phate precipitation technique, with the PTS1R expression 
construct. The SKL proteins colocalized with a peroxiso- 
mal integral membrane protein PMP70 (Fig. 12, C and D). 
The punctate labeling in the injected or transfected cells 
stained for SKL proteins was observed (Fig.  12 A)  only 
when the plasma membrane and peroxisomes were per- 
meabilized  with  digitonin  (25  ~g/ml)  and  Triton X-100 
(1%), but not when the plasma membrane alone was per- 
meabilized  with  digitonin  (compare  Fig.  12,  A  and  B). 
These experiments prove that in group two cells injected 
with the PTS1R cDNA, the SKL proteins relocalize from 
the cytoplasm and reside within the peroxisome. Control 
experiments in which a Zellweger cell line from a different 
complementation group was injected never showed resto- 
ration  of the  punctate  immunofluorescence pattern  for 
SKL proteins (Fig. 11, D, L and J). When the mammalian 
expression vector pJ7lI alone was injected into ALA-T or 
FAIR-T cells, no complementation of the mutant pheno- 
type was observed. Based on these results, it is clear that 
the primary import defect in complementation group two 
disorders can be corrected by PTSIR protein. 
In  the  FAIR-T cell line  both  PTS1  and  PTS2 import 
pathways seem impaired (Figs. 10 E and 11 C). Upon micro- 
injection or transfection of the PTS1R expression construct, 
the  import of PTS2-containing proteins, i.e.,  3-ketoacyl- 
CoA thiolase, was also restored as judged by the appear- 
ance  of  the  characteristic  punctate  fluorescent  pattern 
(Fig. 13). It was noted, however, that only some but not all 
transfected cells showed restoration of PTS2 import. 
Discussion 
The PTSIR Protein Is the Homologue of the P. pastoris 
PTS1 Receptor 
Several lines of evidence suggest that the PTS1R protein is 
the human homologue of the PTS1 receptor. The PTS1R 
DNA exhibits 33.9% identity and 55.1% similarity to the 
P. pastoris  PAS8  protein  (Fig.  2).  The  PTS1R  protein 
binds specifically to an SKL peptide (Fig. 9), as does PAS8 
(McCollum et al.,  1993).  A  PAS8-PTS1R fusion protein 
The Journal of Cell Biology, Volume 130,  1995  60 FigurelO. Presence and subceUular  localization of PMP70, 3-keto-acyl-Coenzyme A thiolase, and catalase in the cultured skin fibroblasts 
from group two peroxisomal disorders. Skin fibroblasts from an nALD patient ALA-T (A-C) and a ZS patient FAIR-T (D-F), belong- 
ing to complementation group two, were processed for immunofluorescence and stained with anti-PMP70 (A and D), anti-thiolase (B 
and E) and anti-catalase (C and F). Bar, 20 Ixm. 
complements the P. pastoris pas8 mutant  for growth on 
oleate  (Table  I).  Both  PAS8,  and  a  small  fraction  of 
PTS1R (Fig. 7, B-D) (McCollum et al., 1993) are localized 
to peroxisomes, and a fraction of these proteins is tightly 
associated with the peroxisomal membrane. Finally, both 
PTS1R and PAS8 complement the selective protein-import 
deficiencies associated with the PTSl-pathway, in human 
and P. pastoris mutant cells, respectively. It is interesting 
to note that the PTS1R antibody recognizes a protein of 
the same size in human, rat, hamster, and monkey ceils, 
suggesting that the protein is conserved in these species. 
Expression and Subcellular Location of  PTS1R 
PTSIR RNA was found in  all human tissues  examined. 
This is not unexpected because peroxisomes comprise an 
essential metabolic compartment in eukaryotic cells. The 
PTS1R  protein  appeared  to  be  highly  soluble  and  was 
mainly recovered in a rat liver cytosolic fraction (Fig. 6). 
Only a small portion was present in a h-fraction, enriched 
in peroxisomes. Analysis of the fractions of a rat liver per- 
oxisome-purification gradient  by  Western  blot  analysis 
shows that most of the PTS1R loaded on the gradient is as- 
sociated with the peroxisomes (Fig. 7 B). In addition, the 
PTS1R protein was localized to peroxisomes in CHO cells 
by indirect immunofluorescence (Fig. 7 D). 
At least part of the PTS1R associated with the rat liver 
peroxisomes  is  insoluble  in  alkaline  sodium  carbonate 
(Fig. 7 C), suggesting that this fraction is tightly associated 
with the peroxisomal membrane. It is intriguing to specu- 
late that PTS1R functions similarly to other proteins in- 
volved in protein transport, such as Escherichia coli Sec A 
and the signal recognition particle, which are known to be 
comprised  of distinct  pools  that  are  cytosolic and  tran- 
siently membrane-associated (Kim et al., 1994; Economou 
and  Wickner,  1994;  Luirink  and  Dobberstein,  1994). 
Wiemer et al  Human PTS1 Receptor Complements Peroxisomal Disorders  61 Figure 11.  PTS1R restores the ability to import SKL-proteins in cultured skin fibroblasts from group two patients with disorders of per- 
oxisome biogenesis. Skin fibroblasts from a control subject PUCK (A), an nALD patient ALA-T (B) and two ZS patients FAIR-T (C) 
and GM4340-T (D), were processed for immunofluorescence  and stained with anti-SKL antibody. A full-length PTS1R expression con- 
struct was microinjected  into the nuclei of ALA-T, FAIR-T, and GM4340-T cells along with a guinea pig IgG to distinguish injected 
ceils from noninjected  cells. (E and F) ALA-T fibroblasts  (complementation group two) that were processed for double-labeling  immu- 
nofluorescence;  E shows a microinjected  cell stained with anti-guinea pig Ig FITC, F shows the corresponding  image stained with rabbit 
anti-SKL and anti-rabbit Ig rhodamine. (G and H) FAIR-T fibroblasts  (complementation group two) and (I and J) GM4340-T fibro- 
blasts (complementation group four) stained as in E and F. Bar, 20 ~m. 
PTSIR might shuttle between the cytosol and the peroxi- 
some in performing its function as the PTS1  receptor. It 
seems clear from the data in Fig. 9 that soluble PTS1R is 
capable  of binding  the  PTS1  peptide.  The  peroxisome- 
bound PTS1R may therefore be relevant to the delivery of 
PTSl-containing  proteins to the  translocation machinery 
on the peroxisomal membrane. 
Chromosomal Location of PTS1R 
PTS1R, the human PTS1 receptor, is assigned to chromo- 
some  12p  by somatic-cell-hybrid-mapping and  indepen- 
dently  confirmed  and  sublocalized  to  band  12p13.3  by 
FISH. No other known human peroxisomal disorders have 
yet been mapped to chromosome 12p. Three other genes 
associated with peroxisomal disorders have been mapped. 
First,  peroxisomal membrane protein  PXMP1  (PMP70), 
has been mapped to chromosome band lp22-p21 (Gartner 
et al., 1993).  Mutations in this gene have been found in pa- 
tients with a generalized peroxisomal dysfunction belong- 
ing  to  complementation  group  one.  The  mouse  homo- 
logue, Pmp-1, is located to chromosome 3 (Gartner et al., 
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imported into the peroxisomal  matrix 
when  cultured  skin fibroblasts  from 
group two peroxisomal  disorders  are 
complemented with PTS1R. Skin fibro- 
blasts from an nALD patient, ALA-T 
as  a  representative of complementa- 
tion group two were transfected with a 
full-length PTS1R expression construct. 
After 48 h the cells were fixed, perme- 
abilized  with  25  ixg/ml digitonin  and 
1% Triton X-100 (A) or with 25 ~g/ml 
digitonin  alone (B),  and stained  with 
anti-SKL  antibody.  Alternatively,  the 
transfected  cells  were  processed  for 
regular  immunofluorescence  and  co- 
stained  with  guinea  pig  anti-PMP70 
(C) and rabbit anti-SKL (D). Species- 
specific  secondary  antibodies  conju- 
gated to different fluorescent  markers 
were used to detect bound primary an- 
tibodies. Bar, 20 p~m. 
1993).  Second,  PXMP3  (peroxisome  assembly  factor  1, 
PMP35), peroxisomal membrane protein-3, was mapped 
to chromosome region 8q21.1 (Masuno et al., 1994). A sin- 
gle  Zellweger  patient,  belonging  to  complementation 
group F (see Shimozawa et al., 1993), was found to have a 
defective gene.  Third,  the  human  peroxisomal  thiolase 
gene  is  located  on  chromosome 3p23-p22  (Bout  et  al., 
1989) and was found deficient in 3-ketoacyl-CoA thiolase 
deficiency (pseudo-ZS). In addition, a microdeletion or in- 
version has been found in ZS patients: del (7)  (7qll.12- 
q11.23)  and  inv  (7)  (p12qll.23)  (Naritomi  et  al.,  1988, 
1989). 
Based on human-mouse comparative mapping data, we 
predict that the mouse homologue of the FFS1 receptor 
gene is located on mouse chromosome 6 in the region be- 
tween 48 and 62 cM (Moore and Elliot, 1993). Two mutant 
loci associated with a  neurological phenotype are within 
the  region  opisthotonus  (opt)  and  deaf  waddler  (dfw) 
(Lane, 1972). The information available on these mutant 
phenotypes is  too  limited  to  evaluate  them  as  possible 
mouse models. 
Involvement of PTS1R in Peroxisomal Protein Import 
The ability of PTS1R to bind SKL peptide (Fig. 9) and the 
inhibition  of  PTSl-specific  import  by  PTSIR  antibody 
(Fig. 8) show that PTSIR is an important component of 
the PTS1 protein-import pathway. We are developing new 
in  vitro  systems  in  which  we  hope  to  address  whether 
PTS1R antibodies also inhibit the PTS2 import pathway, 
but these experiments are still in progress. 
Role of PTSIR in Human Peroxisomal Disorders 
The group two ALA-T cell line displays the same selective 
PTSl-import pathway deficiency as  the P. pastoris pas8 
and S.  cerevisiae paslO  mutants  (McCollum et al.,  1993; 
Van  der Leij  et al.,  1993).  These yeasts and  the human 
ALA-T mutant cell line represent the only ones character- 
ized to date in which import via the PTS1 pathway is selec- 
tively affected. All the other group A  disorders character- 
ized (Motley et al., 1994), as well as a variety of yeast and 
CHO cell mutants (reviewed in Subramani, 1993), are de- 
fective in both the PTS1 and PTS2 import pathways. It is 
not yet clear whether these mutants represent defects in 
peroxisomal protein-import per se, or in the more general 
process of organelle biogenesis. The fact that in the FAIR-T 
cell line both PTS1 and PTS2 pathways seem to be affected 
might be related to the absence of the PTS1R protein in 
this cell line (Fig. 5 B). This observation raises the possibil- 
ity of a  connection between  PTS1  and  PTS2 import  in 
mammalian cells. Interesting in this respect is the recent 
identification of PAS7 as the putative PTS2 receptor in S. 
cerevisiae by Marzoich et al. (1994). The PAS7p contains 
an amino acid sequence motif, the WD-40 repeat. Several 
members of the WD-40 family are known to interact with 
TPR proteins (Goebl and Yanagida, 1991; Van der Voorn 
and Ploegh, 1992). 
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Figure 13.  Complementation of FAIR-T cells with PTSIR also 
restores  import  of  PTS2-containing  proteins.  Skin  fibroblasts 
from a ZS patient FAIR-T, belonging to complementation group 
two, were transfected  with a full-length  PTS1R expression con- 
struct. After 48  h  the cells were processed for immunofluores- 
cence and stained with anti-thiolase.  Bar, 20 Ixm. 
The complementation of the PTSl-import  defect in the 
ZS and nALD cells from group two by the PTS1R cDNA, 
the PTS1  import defect in these cells, and the absence of 
the PTS1R protein in the ZS patient from grottp two argue 
quite strongly that the group two cells are mutated in the 
PTS1R gene. Although the genes (PMP70 and PAF-1)  af- 
fected  in  two  other  complementation  groups  of  ZS  pa- 
tients are known (Gartner  et al.,  1992;  Shimozawa et al., 
1992), nothing is known about the functions of these pro- 
teins. Consequently, the molecular basis of the protein im- 
port  deficiency  is  not understood.  The  correction of the 
import  defect  in  the  group  two  cell  lines  in  our  study 
makes these the only peroxisomal disorders in which the 
molecular basis of the protein-import defect is clearly un- 
derstood. This study also represents one of the few exam- 
ples in which a yeast gene led to the cloning of a  human 
gene that corrects two fatal human disorders at the cellular 
level. It is hoped that this advance will lead, over time, to 
rational ways with which therapies can be sought for these 
devastating diseases. 
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